Pasadena, CA – February 25, 2015.

HeritX founders Joi Morris and Thomas Bock were honored by the Aegis Group of Morgan Stanley for their dedication and groundbreaking work to prevent inherited BRCA cancers and to transform cancer from a disease of treatment, to a disease of prevention. HeritX is a nonprofit research and development organization dedicated to preventing inherited cancers through transformative research integrated with state-of-the-art drug development to make preventive therapies available to families facing inherited BRCA cancers as quickly as possible.

Philanthropic and business leaders from across the greater Los Angeles convened at the Rose Bowl in Pasadena, California on February 25, 2015 for the Annual Aegis Group Nonprofit Celebration event. The Aegis Group at Morgan Stanley is a recognized financial leader that specializes in serving nonprofit organizations nationally. For more than 20 years the Aegis Group has honored individuals whose work makes a tremendous impact on society, communities and in the lives of others. The Aegis Award and the community nonprofit celebration highlight the importance of service for society and humanity.

Kathryn Barger, Chief Deputy to Los Angeles County Supervisor Michael Antonovich, spoke about the importance of the nonprofit community in providing key services to residents of the County of Los Angeles and to society at large. She presented Bock and Morris with commendations from the County of Los Angeles for their critical work to change the paradigm of how we as a society approach cancer.

HeritX is the only organization solely focused on preventing inherited cancer. It’s groundbreaking work in 2015 included focusing researchers on the goal of preventing inherited cancer, convening 30 of the world’s leading experts in research and drug development to the first conference worldwide on preventing inherited BRCA cancer, and developing an integrated R&D roadmap to BRCA prevention in one decade or less.

The BRCA Prevention Roadmap is now guiding scientists around the world in the design and implementation of their prevention research. HeritX’s continues to bring together the best and brightest minds from diverse disciplines to collaborate on achieving prevention, and supports innovative projects that accelerate progress and enable its transfer to other inherited and non-inherited cancers.